Editorial: Redox Metabolism: a Double Edge Sword Sustaining the Adaptive Resistance to Therapy in Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Sep 1

PMID 37655098

Authors

Barbara Marengo

Jose Pedro Friedmann Angeli

Cinzia Domenicotti

Affiliations

Soon will be listed here.

References

Colla R, Izzotti A, Ciucis C, Fenoglio D, Ravera S, Speciale A . Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma. Oncotarget. 2016; 7(43):70715-70737. PMC: 5342585. DOI: 10.18632/oncotarget.12209. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Paul B, Sbodio J, Snyder S . Cysteine Metabolism in Neuronal Redox Homeostasis. Trends Pharmacol Sci. 2018; 39(5):513-524. PMC: 5912966. DOI: 10.1016/j.tips.2018.02.007. View

Tchounwou P, Dasari S, Noubissi F, Ray P, Kumar S . Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy. J Exp Pharmacol. 2021; 13:303-328. PMC: 7987268. DOI: 10.2147/JEP.S267383. View

Pizzimenti S, Ribero S, Cucci M, Grattarola M, Monge C, Dianzani C . Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies. Antioxidants (Basel). 2021; 10(12). PMC: 8750393. DOI: 10.3390/antiox10121942. View

Kumar Sharma P, Varshney R . 2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense. Free Radic Res. 2012; 46(12):1446-57. DOI: 10.3109/10715762.2012.724771. View

Hallmeyer S, Gonzalez R, Lawson D, Cranmer L, Linette G, Puzanov I . Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E. Melanoma Res. 2017; 27(6):585-590. DOI: 10.1097/CMR.0000000000000398. View

Friedmann Angeli J, Krysko D, Conrad M . Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019; 19(7):405-414. DOI: 10.1038/s41568-019-0149-1. View

Diehn M, Cho R, Lobo N, Kalisky T, Dorie M, Kulp A . Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009; 458(7239):780-3. PMC: 2778612. DOI: 10.1038/nature07733. View

10.

Barrera G, Cucci M, Grattarola M, Dianzani C, Muzio G, Pizzimenti S . Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role. Antioxidants (Basel). 2021; 10(4). PMC: 8064392. DOI: 10.3390/antiox10040510. View

11.

Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro A, Pronzato M . Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013; 2013:972913. PMC: 3673338. DOI: 10.1155/2013/972913. View

12.

Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C . Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149(5):1060-72. PMC: 3367386. DOI: 10.1016/j.cell.2012.03.042. View